These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 8214997)

  • 21. Low-dose prednisone therapy for patients with early active rheumatoid arthritis: clinical efficacy, disease-modifying properties, and side effects: a randomized, double-blind, placebo-controlled clinical trial.
    van Everdingen AA; Jacobs JW; Siewertsz Van Reesema DR; Bijlsma JW
    Ann Intern Med; 2002 Jan; 136(1):1-12. PubMed ID: 11777359
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist.
    Bresnihan B; Alvaro-Gracia JM; Cobby M; Doherty M; Domljan Z; Emery P; Nuki G; Pavelka K; Rau R; Rozman B; Watt I; Williams B; Aitchison R; McCabe D; Musikic P
    Arthritis Rheum; 1998 Dec; 41(12):2196-204. PubMed ID: 9870876
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Amiprilose hydrochloride for rheumatoid arthritis.
    Riskin WG; Gillings DB; Scarlett JA
    Ann Intern Med; 1989 Sep; 111(6):455-65. PubMed ID: 2672925
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and tolerability of valdecoxib in treating the signs and symptoms of severe rheumatoid arthritis: a 12-week, multicenter, randomized, double-blind, placebo-controlled study.
    Gibofsky A; Rodrigues J; Fiechtner J; Berger M; Pan S
    Clin Ther; 2007 Jun; 29(6):1071-85. PubMed ID: 17692722
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Randomized double blind trial of an ayurvedic plant derived formulation for treatment of rheumatoid arthritis.
    Chopra A; Lavin P; Patwardhan B; Chitre D
    J Rheumatol; 2000 Jun; 27(6):1365-72. PubMed ID: 10852255
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Double blind placebo controlled trial of pulse treatment with methylprednisolone combined with disease modifying drugs in rheumatoid arthritis.
    Hansen TM; Kryger P; Elling H; Haar D; Kreutzfeldt M; Ingeman-Nielsen MW; Olsson AT; Pedersen C; Rahbek A; Tvede N
    BMJ; 1990 Aug; 301(6746):268-70. PubMed ID: 2202458
    [TBL] [Abstract][Full Text] [Related]  

  • 27. omega-3 Fatty acids infusions as adjuvant therapy in rheumatoid arthritis.
    Bahadori B; Uitz E; Thonhofer R; Trummer M; Pestemer-Lach I; McCarty M; Krejs GJ
    JPEN J Parenter Enteral Nutr; 2010; 34(2):151-5. PubMed ID: 20375422
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunomodulatory and therapeutic effects of Hot-nature diet and co-supplemented hemp seed, evening primrose oils intervention in multiple sclerosis patients.
    Rezapour-Firouzi S; Arefhosseini SR; Mehdi F; Mehrangiz EM; Baradaran B; Sadeghihokmabad E; Mostafaei S; Fazljou SM; Torbati MA; Sanaie S; Zamani F
    Complement Ther Med; 2013 Oct; 21(5):473-80. PubMed ID: 24050582
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of altering dietary essential fatty acids on requirements for non-steroidal anti-inflammatory drugs in patients with rheumatoid arthritis: a double blind placebo controlled study.
    Belch JJ; Ansell D; Madhok R; O'Dowd A; Sturrock RD
    Ann Rheum Dis; 1988 Feb; 47(2):96-104. PubMed ID: 2833184
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safety and efficacy of T-614 in the treatment of patients with active rheumatoid arthritis: a double blind, randomized, placebo-controlled and multicenter trial.
    Lü LJ; Teng JL; Bao CD; Han XH; Sun LY; Xu JH; Li XF; Wu HX
    Chin Med J (Engl); 2008 Apr; 121(7):615-9. PubMed ID: 18466681
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comparative study of etanercept plus methotrexate and methotrexate alone in Taiwanese patients with active rheumatoid arthritis: a 12-week, double-blind, randomized, placebo-controlled study.
    Lan JL; Chou SJ; Chen DY; Chen YH; Hsieh TY; Young M
    J Formos Med Assoc; 2004 Aug; 103(8):618-23. PubMed ID: 15340661
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Borage oil reduction of rheumatoid arthritis activity may be mediated by increased cAMP that suppresses tumor necrosis factor-alpha.
    Kast RE
    Int Immunopharmacol; 2001 Nov; 1(12):2197-9. PubMed ID: 11710548
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cyclosporin A in severe, treatment-refractory rheumatoid arthritis. A randomized study.
    Yocum DE; Klippel JH; Wilder RL; Gerber NL; Austin HA; Wahl SM; Lesko L; Minor JR; Preuss HG; Yarboro C
    Ann Intern Med; 1988 Dec; 109(11):863-9. PubMed ID: 3190040
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of abatacept in patients with methotrexate-resistant active rheumatoid arthritis: a randomized trial.
    Kremer JM; Genant HK; Moreland LW; Russell AS; Emery P; Abud-Mendoza C; Szechinski J; Li T; Ge Z; Becker JC; Westhovens R
    Ann Intern Med; 2006 Jun; 144(12):865-76. PubMed ID: 16785475
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial.
    Smolen JS; Beaulieu A; Rubbert-Roth A; Ramos-Remus C; Rovensky J; Alecock E; Woodworth T; Alten R;
    Lancet; 2008 Mar; 371(9617):987-97. PubMed ID: 18358926
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intravenous golimumab is effective in patients with active rheumatoid arthritis despite methotrexate therapy with responses as early as week 2: results of the phase 3, randomised, multicentre, double-blind, placebo-controlled GO-FURTHER trial.
    Weinblatt ME; Bingham CO; Mendelsohn AM; Kim L; Mack M; Lu J; Baker D; Westhovens R
    Ann Rheum Dis; 2013 Mar; 72(3):381-9. PubMed ID: 22661646
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MRI assessment of early response to certolizumab pegol in rheumatoid arthritis: a randomised, double-blind, placebo-controlled phase IIIb study applying MRI at weeks 0, 1, 2, 4, 8 and 16.
    Østergaard M; Jacobsson LT; Schaufelberger C; Hansen MS; Bijlsma JW; Dudek A; Rell-Bakalarska M; Staelens F; Haake R; Sundman-Engberg B; Bliddal H
    Ann Rheum Dis; 2015 Jun; 74(6):1156-63. PubMed ID: 25512675
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Etanercept therapy in rheumatoid arthritis. A randomized, controlled trial.
    Moreland LW; Schiff MH; Baumgartner SW; Tindall EA; Fleischmann RM; Bulpitt KJ; Weaver AL; Keystone EC; Furst DE; Mease PJ; Ruderman EM; Horwitz DA; Arkfeld DG; Garrison L; Burge DJ; Blosch CM; Lange ML; McDonnell ND; Weinblatt ME
    Ann Intern Med; 1999 Mar; 130(6):478-86. PubMed ID: 10075615
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fish-oil fatty acid supplementation in active rheumatoid arthritis. A double-blinded, controlled, crossover study.
    Kremer JM; Jubiz W; Michalek A; Rynes RI; Bartholomew LE; Bigaouette J; Timchalk M; Beeler D; Lininger L
    Ann Intern Med; 1987 Apr; 106(4):497-503. PubMed ID: 3030173
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical improvement as reflected in measures of function and health-related quality of life following treatment with leflunomide compared with methotrexate in patients with rheumatoid arthritis: sensitivity and relative efficiency to detect a treatment effect in a twelve-month, placebo-controlled trial. Leflunomide Rheumatoid Arthritis Investigators Group.
    Tugwell P; Wells G; Strand V; Maetzel A; Bombardier C; Crawford B; Dorrier C; Thompson A
    Arthritis Rheum; 2000 Mar; 43(3):506-14. PubMed ID: 10728742
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.